Clinical Trials Logo

Femoral Fracture clinical trials

View clinical trials related to Femoral Fracture.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04015154 Active, not recruiting - Femoral Fracture Clinical Trials

A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With the Femoral Nail PF

Start date: September 12, 2019
Phase:
Study type: Observational

This investigation is a prospective, multicenter clinical investigation. It is anticipated that a total of 50 subjects will be enrolled at up to 5 sites. Enrollment is estimated to commence in Q4 of 2018. Neither subjects nor investigators are blinded to treatment and the clinical investigation includes a historical control which will be compared to the Femoral Nail PF of the T2 Alpha Femur Antegrade GT/PF Nailing System. Total duration of enrollment, 12 month follow-up and analysis is expected to take 29 months. The clinical investigation has been designed to follow the surgeon's standard of care for femur fractured subjects, in addition to a 12 month follow-up visit. The primary endpoint of this clinical investigation is to confirm efficacy/performance at 12 months, as measured by the Lower Extremity Measure (LEM). Confirmation of efficacy/performance at 12 months will be based on an equal or greater (non-inferior) LEM score result of the Femoral Nail PF of the T2 Alpha Femur Antegrade GT/PF Nailing System compared to the T2 Femur benchmark literature.